1985
DOI: 10.1016/s0049-0172(85)80012-3
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology of diclofenac sodium (Voltaren®)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
3
0
1

Year Published

1986
1986
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 1 publication
0
3
0
1
Order By: Relevance
“…aeruginosa. Many studies reported that Diclofenac sodium is a potent antiinflammatory, analgesic, anti-pyretic agent and in reducing the post-operative endodontic pain with less gastrointestinal side effects [37,38,39,40,41]. Diclofenac was found to show antibacterial effect against both grampositive and gram-negative bacteria and synergism with other antibiotics [42,43,44,45].…”
Section: Discussionmentioning
confidence: 99%
“…aeruginosa. Many studies reported that Diclofenac sodium is a potent antiinflammatory, analgesic, anti-pyretic agent and in reducing the post-operative endodontic pain with less gastrointestinal side effects [37,38,39,40,41]. Diclofenac was found to show antibacterial effect against both grampositive and gram-negative bacteria and synergism with other antibiotics [42,43,44,45].…”
Section: Discussionmentioning
confidence: 99%
“…While DCF is better tolerated than nonselective NSAIDs such as indomethacin, it is still associated with a variety of toxic small intestinal side effects. 30,31 A typical therapeutic dose of DCF (50 mg orally) translates into local concentrations between 300 and 1600 μM of DCF within the intestinal lumen (assuming an intestinal fluid volume of between 0.1 and 0.5 L). 32 Therefore, we employed a range of DCF between 500 and 1000 μM to recapitulate an intraluminal physiologically relevant concentration.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Diclofenac (2-(2,6-dichloroanilino) phenylacetic acid; DCF) has an approximately 10-fold higher preference for the COX-2 isoenzyme versus COX-1 and is primarily ingested orally, although it may also be administered via topical, intravenous, intramuscular, and intrarectal routes. While DCF is better tolerated than nonselective NSAIDs such as indomethacin, it is still associated with a variety of toxic small intestinal side effects. , A typical therapeutic dose of DCF (50 mg orally) translates into local concentrations between 300 and 1600 μM of DCF within the intestinal lumen (assuming an intestinal fluid volume of between 0.1 and 0.5 L) . Therefore, we employed a range of DCF between 500 and 1000 μM to recapitulate an intraluminal physiologically relevant concentration.…”
Section: Results and Discussionmentioning
confidence: 99%
“…Der Einfluß verschiedener nicht-steroidaler Antiphlogistika auf die ebenfalls am Entzündungsprozeß beteiligten Leukotriene wurde von mehreren Autoren beschrieben (7,8,26,27,28,34,35). Hierbei zeigte sich kein einheitliches Verhalten der NSAID.…”
Section: Diskussionunclassified